LIDOCAINE HYDROCHLORIDE (LIDOCAINE HYDROCHLORIDE) — FDA Approval ANDA080420 (ABRAXIS PHARM)
LIDOCAINE HYDROCHLORIDE (LIDOCAINE HYDROCHLORIDE) — FDA Approval ANDA080420 (ABRAXIS PHARM) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: LIDOCAINE HYDROCHLORIDE; Active ingredients: LIDOCAINE HYDROCHLORIDE; Application number: ANDA080420.
| Brand name | LIDOCAINE HYDROCHLORIDE |
|---|---|
| Active ingredients | LIDOCAINE HYDROCHLORIDE |
| Application number | ANDA080420 |
| Sponsor | ABRAXIS PHARM |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Discontinued |
| Products in application | 4 |
| First approval date | 19720215 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →